4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-036637
Options or other derivatives
- CEO and President acquired 30,679 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kendall Keith J CEO and President | 2018-08-15 | Grant or award · Stock Option (Right to Purchase) | +28,043 | 28,043 | D | ||
| Kendall Keith J CEO and President | 2018-08-15 | Grant or award · Restricted Stock Unit | +2,636 | 2,636 | D | ||
Loading xslF345X03/form4.xml…